{"id":"https://openalex.org/W2272059546","doi":"https://doi.org/10.1016/j.rmed.2016.02.001","title":"Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS\u00ae trials","display_name":"Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS\u00ae trials","publication_year":2016,"publication_date":"2016-02-02","ids":{"openalex":"https://openalex.org/W2272059546","doi":"https://doi.org/10.1016/j.rmed.2016.02.001","mag":"2272059546","pmid":"https://pubmed.ncbi.nlm.nih.gov/26915984"},"language":"en","primary_location":{"id":"doi:10.1016/j.rmed.2016.02.001","doi":"https://doi.org/10.1016/j.rmed.2016.02.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rmed.2016.02.001","pdf_url":"http://www.resmedjournal.com/article/S0954611116300191/pdf","source":{"id":"https://openalex.org/S71995303","display_name":"Respiratory Medicine","issn_l":"0954-6111","issn":["0954-6111","1532-3064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.resmedjournal.com/article/S0954611116300191/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019441565","display_name":"Luca Richeldi","orcid":"https://orcid.org/0000-0001-8594-1448","observed_orcids":["https://orcid.org/0000-0001-8594-1448"]},"institutions":[{"id":"https://openalex.org/I34931013","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08","country_code":"GB","type":"government","lineage":["https://openalex.org/I34931013"]},{"id":"https://openalex.org/I4210110707","display_name":"NIHR Southampton Respiratory Biomedical Research Unit","ror":"https://ror.org/01yg3ff09","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802965805","https://openalex.org/I34931013","https://openalex.org/I4210110707","https://openalex.org/I4210118229","https://openalex.org/I43439940"]},{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Luca Richeldi","raw_affiliation_strings":["National Institute for Health Research, Southampton Respiratory Biomedical Research Unit and Clinical and Experimental Sciences, University of Southampton, University Road, Southampton, SO17 1BJ, UK. Electronic address: L.Richeldi@soton.ac.uk","National Institute for Health Research, Southampton Respiratory Biomedical Research Unit and Clinical and Experimental Sciences, University of Southampton, University Road, Southampton, SO17 1BJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute for Health Research, Southampton Respiratory Biomedical Research Unit and Clinical and Experimental Sciences, University of Southampton, University Road, Southampton, SO17 1BJ, UK. Electronic address: L.Richeldi@soton.ac.uk","institution_ids":["https://openalex.org/I34931013","https://openalex.org/I4210110707","https://openalex.org/I43439940"]},{"raw_affiliation_string":"National Institute for Health Research, Southampton Respiratory Biomedical Research Unit and Clinical and Experimental Sciences, University of Southampton, University Road, Southampton, SO17 1BJ, UK","institution_ids":["https://openalex.org/I34931013","https://openalex.org/I4210110707","https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014703126","display_name":"Vincent Cottin","orcid":"https://orcid.org/0000-0002-5591-0955","observed_orcids":["https://orcid.org/0000-0002-5591-0955"]},"institutions":[{"id":"https://openalex.org/I100532134","display_name":"Lyon 1 Universit\u00e9","ror":"https://ror.org/029brtt94","country_code":"FR","type":"education","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264"]},{"id":"https://openalex.org/I4210136143","display_name":"H\u00f4pital Louis Pradel","ror":"https://ror.org/0396v4y86","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210136143"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Vincent Cottin","raw_affiliation_strings":["Louis Pradel Hospital, Claude Bernard University Lyon 1, 28 Avenue du Doyen Lepine, 69677, Bron Cedex, Lyon, France. Electronic address: vincent.cottin@chu-lyon.fr","Louis Pradel Hospital, Claude Bernard University Lyon 1, 28 Avenue du Doyen Lepine, 69677, Bron Cedex, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louis Pradel Hospital, Claude Bernard University Lyon 1, 28 Avenue du Doyen Lepine, 69677, Bron Cedex, Lyon, France. Electronic address: vincent.cottin@chu-lyon.fr","institution_ids":["https://openalex.org/I100532134","https://openalex.org/I4210136143"]},{"raw_affiliation_string":"Louis Pradel Hospital, Claude Bernard University Lyon 1, 28 Avenue du Doyen Lepine, 69677, Bron Cedex, Lyon, France","institution_ids":["https://openalex.org/I100532134","https://openalex.org/I4210136143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114002768","display_name":"Roland M. du Bois","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Roland M. du Bois","raw_affiliation_strings":["Imperial College, London, SW7 2AZ, UK. Electronic address: ron@du-bois.co.uk","Imperial College, London, SW7 2AZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial College, London, SW7 2AZ, UK. Electronic address: ron@du-bois.co.uk","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Imperial College, London, SW7 2AZ, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027510239","display_name":"Mois\u00e9s Selman","orcid":"https://orcid.org/0000-0002-1022-4783","observed_orcids":["https://orcid.org/0000-0002-1022-4783"]},"institutions":[{"id":"https://openalex.org/I4210102695","display_name":"Instituto Nacional de Enfermedades Respiratorias","ror":"https://ror.org/017fh2655","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210102695"]}],"countries":["MX"],"is_corresponding":true,"raw_author_name":"Mois\u00e9s Selman","raw_affiliation_strings":["Instituto Nacional de Enfermedades Respiratorias, Calz. de Tlalpan 4502, Tlalpan, Mexico City, D.F., Mexico. Electronic address: mselmanl@yahoo.com.mx","Instituto Nacional de Enfermedades Respiratorias, Calz. de Tlalpan 4502, Tlalpan, Mexico City, D.F., Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Enfermedades Respiratorias, Calz. de Tlalpan 4502, Tlalpan, Mexico City, D.F., Mexico. Electronic address: mselmanl@yahoo.com.mx","institution_ids":["https://openalex.org/I4210102695"]},{"raw_affiliation_string":"Instituto Nacional de Enfermedades Respiratorias, Calz. de Tlalpan 4502, Tlalpan, Mexico City, D.F., Mexico","institution_ids":["https://openalex.org/I4210102695"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100668639","display_name":"Toshio Kimura","orcid":"https://orcid.org/0000-0002-8089-4299","observed_orcids":["https://orcid.org/0000-0002-8089-4299"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Toshio Kimura","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216, Ingelheim am Rhein, Germany. Electronic address: toshio.kimura@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216, Ingelheim am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216, Ingelheim am Rhein, Germany. Electronic address: toshio.kimura@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216, Ingelheim am Rhein, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078809766","display_name":"Zelie Bailes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112752","display_name":"Boehringer Ingelheim (United Kingdom)","ror":"https://ror.org/01jnnpe14","country_code":"GB","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210112752"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Zelie Bailes","raw_affiliation_strings":["Boehringer Ingelheim Ltd., Ellesfield Avenue, Bracknell, West Berkshire, RG12 8YS, UK. Electronic address: zelie.bailes@boehringer-ingelheim.com","Boehringer Ingelheim Ltd., Ellesfield Avenue, Bracknell, West Berkshire, RG12 8YS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Ltd., Ellesfield Avenue, Bracknell, West Berkshire, RG12 8YS, UK. Electronic address: zelie.bailes@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I4210112752"]},{"raw_affiliation_string":"Boehringer Ingelheim Ltd., Ellesfield Avenue, Bracknell, West Berkshire, RG12 8YS, UK","institution_ids":["https://openalex.org/I4210112752"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078029953","display_name":"Rozsa Schlenker\u2010Herceg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rozsa Schlenker-Herceg","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA. Electronic address: rozsa.schlenker-herceg@boehringer-ingelheim.com","Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA. Electronic address: rozsa.schlenker-herceg@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I4210160255"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091576695","display_name":"Susanne Stowasser","orcid":"https://orcid.org/0009-0008-6013-0225","observed_orcids":["https://orcid.org/0009-0008-6013-0225"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Susanne Stowasser","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216, Ingelheim am Rhein, Germany. Electronic address: susanne.stowasser@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216, Ingelheim am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216, Ingelheim am Rhein, Germany. Electronic address: susanne.stowasser@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216, Ingelheim am Rhein, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042957984","display_name":"Kevin M. Brown","orcid":"https://orcid.org/0000-0002-8558-6711","observed_orcids":["https://orcid.org/0000-0002-8558-6711"]},"institutions":[{"id":"https://openalex.org/I3019586173","display_name":"National Jewish Health","ror":"https://ror.org/016z2bp30","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019586173"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kevin K. Brown","raw_affiliation_strings":["National Jewish Health, 1400 Jackson St, Denver, CO, 80206, USA. Electronic address: brownk@njhealth.org","National Jewish Health, 1400 Jackson St, Denver, CO, 80206, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Jewish Health, 1400 Jackson St, Denver, CO, 80206, USA. Electronic address: brownk@njhealth.org","institution_ids":["https://openalex.org/I3019586173"]},{"raw_affiliation_string":"National Jewish Health, 1400 Jackson St, Denver, CO, 80206, USA","institution_ids":["https://openalex.org/I3019586173"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5014703126","https://openalex.org/A5019441565","https://openalex.org/A5027510239","https://openalex.org/A5042957984","https://openalex.org/A5078029953","https://openalex.org/A5078809766","https://openalex.org/A5091576695","https://openalex.org/A5100668639","https://openalex.org/A5114002768"],"corresponding_institution_ids":["https://openalex.org/I100532134","https://openalex.org/I1330995197","https://openalex.org/I3019586173","https://openalex.org/I34931013","https://openalex.org/I4210102695","https://openalex.org/I4210110707","https://openalex.org/I4210112752","https://openalex.org/I4210136143","https://openalex.org/I4210160255","https://openalex.org/I43439940","https://openalex.org/I47508984"],"apc_list":{"value":3630,"currency":"USD","value_usd":3630},"apc_paid":{"value":3630,"currency":"USD","value_usd":3630},"fwci":43.5626,"has_fulltext":true,"cited_by_count":474,"citation_normalized_percentile":{"value":0.99881868,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"113","issue":null,"first_page":"74","last_page":"79"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nintedanib","display_name":"nintedanib","score":0.9580000042915344},{"id":"https://openalex.org/keywords/idiopathic-pulmonary-fibrosis","display_name":"idiopathic pulmonary fibrosis","score":1.0},{"id":"https://openalex.org/keywords/inpulsis-trials","display_name":"INPULSIS trials","score":0.9679999947547913},{"id":"https://openalex.org/keywords/fvc-decline","display_name":"forced vital capacity decline","score":0.9539999961853027},{"id":"https://openalex.org/keywords/acute-exacerbation","display_name":"acute exacerbation","score":0.9559999704360962},{"id":"https://openalex.org/keywords/st-george-s-respiratory-questionnaire","display_name":"St George's Respiratory Questionnaire","score":0.9879999756813049},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.9580000042915344},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5820000171661377},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.6269999742507935},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7870000004768372},{"id":"https://openalex.org/keywords/antifibrotic-therapy","display_name":"antifibrotic therapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/treatment-effect-estimation","display_name":"treatment effect estimation","score":0.49300000071525574},{"id":"https://openalex.org/keywords/pooled-analysis","display_name":"pooled analysis","score":0.4819999933242798}],"concepts":[{"id":"https://openalex.org/C2780171596","wikidata":"https://www.wikidata.org/wiki/Q15149723","display_name":"Nintedanib","level":4,"score":0.9941028952598572},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9503530263900757},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.8587362766265869},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42151695489883423},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39073145389556885},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3746832311153412},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.14998304843902588}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014797","descriptor_name":"Vital Capacity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054990","descriptor_name":"Idiopathic Pulmonary Fibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054990","descriptor_name":"Idiopathic Pulmonary Fibrosis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.rmed.2016.02.001","doi":"https://doi.org/10.1016/j.rmed.2016.02.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rmed.2016.02.001","pdf_url":"http://www.resmedjournal.com/article/S0954611116300191/pdf","source":{"id":"https://openalex.org/S71995303","display_name":"Respiratory Medicine","issn_l":"0954-6111","issn":["0954-6111","1532-3064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory Medicine","raw_type":"journal-article"},{"id":"pmid:26915984","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26915984","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory medicine","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.soton.ac.uk:443355","doi":null,"is_oa":false,"landing_page_url":"http://doi.org/10.1016/j.rmed.2016.02.001>).","pdf_url":null,"source":{"id":"https://openalex.org/S4306401019","display_name":"ePrints Soton (University of Southampton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I43439940","host_organization_name":"University of Southampton","host_organization_lineage":["https://openalex.org/I43439940"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1016/j.rmed.2016.02.001","doi":"https://doi.org/10.1016/j.rmed.2016.02.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rmed.2016.02.001","pdf_url":"http://www.resmedjournal.com/article/S0954611116300191/pdf","source":{"id":"https://openalex.org/S71995303","display_name":"Respiratory Medicine","issn_l":"0954-6111","issn":["0954-6111","1532-3064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310441","display_name":"Boehringer Ingelheim","ror":"https://ror.org/00q32j219"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2272059546.pdf","grobid_xml":"https://content.openalex.org/works/W2272059546.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1757222072","https://openalex.org/W1954728404","https://openalex.org/W1975158384","https://openalex.org/W2003201331","https://openalex.org/W2079311676","https://openalex.org/W2110871781","https://openalex.org/W2117488044","https://openalex.org/W2120791222","https://openalex.org/W2138871107","https://openalex.org/W2147416874","https://openalex.org/W2152974152","https://openalex.org/W2157869208","https://openalex.org/W2167383172","https://openalex.org/W2315538569","https://openalex.org/W2478829584"],"related_works":["https://openalex.org/W2584842100","https://openalex.org/W2322924860","https://openalex.org/W2337387038","https://openalex.org/W2315495746","https://openalex.org/W1975158384","https://openalex.org/W2334396633","https://openalex.org/W2765483607","https://openalex.org/W2603748508","https://openalex.org/W3000956463","https://openalex.org/W2771028911"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"PURPOSE:":[2],"The":[3,138,216],"Phase":[4,10],"II":[5],"TOMORROW":[6],"trial":[7],"and":[8,17,47,59,89,123,171,190,202],"two":[9],"III":[11],"INPULSIS(\u00ae)":[12],"trials":[13,54],"investigated":[14],"the":[15,36,108,222,227,233],"efficacy":[16],"safety":[18],"of":[19,35,39,49,66,114,214,237,244],"nintedanib":[20,40,122,170,234,241],"versus":[21,242],"placebo":[22,101,127,174],"in":[23,68,81,107,116,161,212,232,259],"patients":[24,96,238,245,260],"with":[25,121,126,169,173,221,240,247,261],"idiopathic":[26],"pulmonary":[27],"fibrosis":[28],"(IPF).":[29],"To":[30],"obtain":[31],"an":[32],"overall":[33],"estimate":[34],"treatment":[37],"effect":[38,254],"150":[41],"mg":[42],"twice":[43],"daily":[44],"(bid),":[45],"pooled":[46,109,223],"meta-analyses":[48,60],"data":[50],"from":[51,79,159],"these":[52],"three":[53],"were":[55,61,105,193],"conducted.":[56],"METHODS:":[57],"Pooled":[58],"conducted":[62],"for":[63,141,186],"annual":[64,112],"rate":[65,113],"decline":[67,115],"forced":[69],"vital":[70],"capacity":[71],"(FVC),":[72],"time":[73,142,187],"to":[74,143,188],"first":[75,144],"acute":[76,145],"exacerbation,":[77],"change":[78,158],"baseline":[80,160],"St":[82],"George's":[83],"Respiratory":[84],"Questionnaire":[85],"(SGRQ)":[86],"total":[87],"score":[88,163],"mortality":[90,192],"over":[91],"52":[92,166],"weeks.":[93],"RESULTS:":[94],"1231":[95],"(nintedanib":[97],"n":[98,102],"=":[99,103,154,182,200,209],"723,":[100],"508)":[104],"included":[106],"analysis.":[110,224],"Adjusted":[111,156],"FVC":[117],"was":[118,147,167,218,226],"-112.4":[119],"mL/year":[120,125,130],"-223.3":[124],"(difference:":[128,175],"110.9":[129],"[95%":[131,177],"CI:":[132,150,178,196,205],"78.5,":[133],"143.3];":[134],"p":[135,153,181,199,208],"<":[136],"0.0001).":[137],"hazard":[139],"ratio":[140],"exacerbation":[146],"0.53":[148],"(95%":[149,195,204],"0.34,":[151,206],"0.83;":[152],"0.0047).":[155],"mean":[157],"SGRQ":[162],"at":[164],"week":[165],"2.92":[168],"4.97":[172],"-2.05":[176],"-3.59,":[179],"-0.50];":[180],"0.0095).":[183],"Hazard":[184],"ratios":[185],"all-cause":[189],"on-treatment":[191],"0.70":[194],"0.46,":[197],"1.08;":[198],"0.0954)":[201],"0.57":[203],"0.97;":[207],"0.0274),":[210],"respectively,":[211],"favour":[213],"nintedanib.":[215],"meta-analysis":[217],"generally":[219],"consistent":[220],"Diarrhoea":[225],"most":[228],"frequent":[229],"adverse":[230],"event":[231],"group":[235],"(61.5%":[236],"treated":[239,246],"17.9%":[243],"placebo).":[248],"CONCLUSION:":[249],"Nintedanib":[250],"has":[251],"a":[252],"beneficial":[253],"on":[255],"slowing":[256],"disease":[257],"progression":[258],"IPF.":[262]},"counts_by_year":[{"year":2026,"cited_by_count":20},{"year":2025,"cited_by_count":29},{"year":2024,"cited_by_count":46},{"year":2023,"cited_by_count":41},{"year":2022,"cited_by_count":43},{"year":2021,"cited_by_count":65},{"year":2020,"cited_by_count":52},{"year":2019,"cited_by_count":56},{"year":2018,"cited_by_count":55},{"year":2017,"cited_by_count":55},{"year":2016,"cited_by_count":11},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}